LIVAGEN INJECTOR PEN 3ML

Livagen (Lys-Glu-Asp-Ala / KEDA): The Advanced Hepatic Bioregulator for Chromatin Remodeling, Hepatocyte Renewal, and Liver Function Restoration — Now Available in the UAE

The peptide Livagen is a tetrapeptide KEDA that has been synthesized from a naturally occurring complex of peptides isolated from liver tissue. It was first synthesized based on an analysis of the amino acids found in these natural peptide complexes. The specific properties of the peptide demonstrate significant tropism for hepatocyte cells, as well as demonstrated epigenetic changes when administered to the cells, especially an effect to decondense heterochromatin in the cell nucleus.

The primary mechanism through which Livagen acts is through the induction of chromatin deheterochromatinization. This is essentially “unlocking” areas of DNA where transcription is silenced due to either aging, oxidative stress, exposure to toxins, or chronic liver dysfunction. Through this process of altering the structure of heterochromatin, ribosomal gene expression is increased; protein synthesis is enhanced; detoxifying enzyme activity is increased; and metabolic processes are restored in hepatocytes. Additionally, there appears to be a reduction of modulating activities for enkephaline-degrading enzymes; and an increase in cellular resilience.

This level of epigenetic remodeling places Livagen as one of the most valuable tools used in the investigation of aging related declines in liver function; detoxifying capabilities of the liver; NAFLD; toxin induced damage to the liver; chronic hepatitis recovery; prevention of fibrosis; and geroprotective strategies to restore young liver function. Additionally, the mechanisms through which Livagen works with chromatin and protein synthesis make it relevant to many additional studies related to cellular aging; metabolic regulation; and tissue regeneration.

Our Premium Injector Pen delivers a precise formulation of 3 milliliters of a highly purified (>99%) peptide solution. The product is made using quality control measures that ensure each dose will have consistent purity levels and will deliver the highest possible bioavailability to the target tissue. Our convenient subcutaneous delivery system provides researchers with a proven method for administering their study participants accurately and efficiently. While our injector pen design is perfect for short term studies, it also allows researchers to conduct long cyclic studies without compromising the stability of the peptide solution.

Below, explore six key research-supported potential benefits of Livagen, grounded in mechanistic preclinical data, cellular studies, and Khavinson bioregulator science.

1. Chromatin Remodeling and Epigenetic Gene Reactivation
Livagen causes decondensation of the pericentric heterochromatin and stimulates ribosomal genes in aging cells. By releasing suppressed areas of DNA that have been epigenetically silenced this process allows for a restoration of transcripional processes important to youthful cellular development and function. Studies conducted by Lezhava et al. in lymphocytes from individuals aged 75-88 revealed significant decondensation of heterochromatin as well as an increase in sister chromatatid exchange events and activation of nucleolus organizer regions — indicating its ability to stimulate gene expression.

2. Normalization of Hepatocyte Protein Synthesis
Livagen is able to restore in hepatocytes a previously diminished capacity for de novo protein synthesis that occurs with advancing age through both increasing transcription of genes associated with ribosome biogenesis and improving function of the endoplasmic reticulum. When hepatocyte cell culture was derived from aging rats, application of nanomolar concentrations of Livagen resulted in a significant increase (almost up to the level seen in young) in rate of protein synthesis, in addition to this effect on protein synthesis, it will renormalize production of many critical liver-produced proteins including albumin, transferrin, etc., which are responsible for normal hepatic biosynthesis.

3. Enhancement of Hepatic Detoxification Pathways
Livagen increases the liver’s detoxifying capabilities by significantly increasing the amount of cytochrome P-450 enzyme (phase I) as well as increasing the expression of all major phase II conjugating enzymes and also its own antioxidants. This has greatly improved the liver’s overall ability to metabolically degrade and excrete a wide variety of substances that can be considered foreign (xenobiotics), drugs or normal metabolic waste products.

4. Hepatoprotective and Anti-Apoptotic Effects
Livagen has been shown to protect the structure of the liver by reducing apoptosis in hepatocytes, inhibiting the development of fibrosis within the tissue through suppression of fibrogenic signaling, and maintains liver tissue architecture during a variety of stressors. Studies have demonstrated that, when administered in models of hepatic damage, livagen is capable of significantly reducing levels of elevated liver enzymes (AST and ALT), as well as limiting the inflammatory response and the subsequent progression of fibrosis associated with these injuries.

The protective effects against cellular injury exhibited by Livagen would be an excellent model for studying various types of both chronic and acute liver injury, as well as the role of fibrosis in regenerating injured livers.

5. Restoration of Metabolic Liver Functions
By reactivating genes involved in gluconeogenesis, lipid metabolism, bile acid synthesis, and carbohydrate handling, Livagen helps normalize complex metabolic processes often disrupted in aging or metabolic syndrome. Preclinical observations report improved lipid profiles, better glucose handling, and enhanced overall metabolic stability in treated aged models.

6. Broader Anti-Aging and Systemic Support
In addition to its direct impact on the liver, Livagen’s ability to modulate the structure of chromatin is thought to contribute to the overall “rejuvenation” of cells; restoration of normal circadian rhythms in metabolic pathways; and possibly immune system stimulation by affecting the number or characteristics of lymphocytes. Additionally, Livagen has been found to counteract senescent associated heterochromatization of chromosomes within all organ systems. Thus, it appears that Livagen may serve as an attractive compound for research into integrated longevity; epigenetic aspects of aging (epigenetic gerontology); and multi-organ studies which include evaluation of how liver health affects overall body health.

Why Choose Our Livagen Injector Pen?

Our Livagen is manufactured by companies with a long history of producing peptides according to the methods developed by Dr. Khavinson. All of our products are tested for purity, strength (potency), identity, sterility and shelf life by an independent third party. Each batch is evaluated against strict quality guidelines that ensure reliable results can be obtained when conducting sensitive studies such as those concerning the epigenetics of aging, liver function, etc.

Our precision designed injector pen makes it easy to administer Livagen subcutaneously. The injector pens provide a convenient means of accurately controlling dose, minimizing waste and have been shown to maintain their potency for long periods of time. Injector pens make it easy to use Livagen in laboratory or clinical study settings where consistent dosing over multiple days or cycles is necessary.

Livagen is one of few commercially available bioregulatory agents that has been extensively studied for its ability to remodel chromatin; i.e., alter gene expression, and specifically target the liver. As such, Livagen represents a powerful epigenetic tool which will allow scientists to explore mechanisms involved in liver regeneration, enhanced removal of toxins from the body, and reversing many manifestations of aging at the molecular level.

Before using any product please contact a licensed health care professional, your research ethics committee or Institutional Review Board. The information contained herein is strictly based upon published scientific literature and is provided solely for educational and informative purposes only. Any statements made regarding potential uses of this product should NOT be considered as medical claims related to diagnosing, treating, curing or preventing ANY diseases.

Important Note: This product is intended strictly for research and laboratory use only. It is not for personal consumption, human or animal therapeutic use, or any clinical application. Please consult and fully comply with all local regulations in the UAE before purchasing or handling.